Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine vs Beta-blockers in Inappropriate Sinus Tachycardia
NCT01657136Phase 3Completed
- Sponsor
- Policlinico Casilino
- Start
- Sep 2013
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ivabradine in inappropriate sinus tachycardia (IST), sponsored by Policlinico Casilino. Started Sep 2013; status: completed.
02
Drugs
ivabradine
03
Conditions
inappropriate sinus tachycardia (IST)
Beyond the preview
Go deeper on NCT01657136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01657136.